136 related articles for article (PubMed ID: 16111718)
1. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
Jonsson KO; Persson E; Fowler CJ
Life Sci; 2006 Jan; 78(6):598-606. PubMed ID: 16111718
[TBL] [Abstract][Full Text] [Related]
2. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.
Mazzari S; Canella R; Petrelli L; Marcolongo G; Leon A
Eur J Pharmacol; 1996 Apr; 300(3):227-36. PubMed ID: 8739213
[TBL] [Abstract][Full Text] [Related]
3. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
Bueb JL; Lambert DM; Tschirhart EJ
Biochim Biophys Acta; 2001 Apr; 1538(2-3):252-9. PubMed ID: 11336796
[TBL] [Abstract][Full Text] [Related]
4. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
[TBL] [Abstract][Full Text] [Related]
5. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
Conti S; Costa B; Colleoni M; Parolaro D; Giagnoni G
Br J Pharmacol; 2002 Jan; 135(1):181-7. PubMed ID: 11786493
[TBL] [Abstract][Full Text] [Related]
6. Effects of water-soluble cigarette smoke extracts upon the release of beta-hexosaminidase from RBL-2H3 basophilic leukaemia cells in response to substance P, compound 48/80, concanavalin A and antigen stimulation.
Fowler CJ; Sandberg M; Tiger G
Inflamm Res; 2003 Nov; 52(11):461-9. PubMed ID: 14652680
[TBL] [Abstract][Full Text] [Related]
7. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis.
Storr MA; Keenan CM; Zhang H; Patel KD; Makriyannis A; Sharkey KA
Inflamm Bowel Dis; 2009 Nov; 15(11):1678-85. PubMed ID: 19408320
[TBL] [Abstract][Full Text] [Related]
8. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
9. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells.
Esquisatto LC; Costa SK; Camargo EA; Ribela MT; Brain SD; de Nucci G; Antunes E
Br J Pharmacol; 2001 Sep; 134(1):108-15. PubMed ID: 11522602
[TBL] [Abstract][Full Text] [Related]
10. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leukaemic cells.
Granberg M; Fowler CJ; Jacobsson SO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):66-73. PubMed ID: 11485041
[TBL] [Abstract][Full Text] [Related]
12. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
13. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story..
Dalle Carbonare M; Del Giudice E; Stecca A; Colavito D; Fabris M; D'Arrigo A; Bernardini D; Dam M; Leon A
J Neuroendocrinol; 2008 May; 20 Suppl 1():26-34. PubMed ID: 18426496
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
Michler T; Storr M; Kramer J; Ochs S; Malo A; Reu S; Göke B; Schäfer C
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G181-92. PubMed ID: 23139224
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of norathyriol, a xanthone from Tripterospermum lanceolatum, on cutaneous plasma extravasation.
Wang JP; Raung SL; Lin CN; Teng CM
Eur J Pharmacol; 1994 Jan; 251(1):35-42. PubMed ID: 7511107
[TBL] [Abstract][Full Text] [Related]
16. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
Lunn CA; Fine JS; Rojas-Triana A; Jackson JV; Fan X; Kung TT; Gonsiorek W; Schwarz MA; Lavey B; Kozlowski JA; Narula SK; Lundell DJ; Hipkin RW; Bober LA
J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Baldassano S; Serio R; Mule' F
Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
19. Histamine modulates mast cell degranulation through an indirect mechanism in a model IgE-mediated reaction.
Carlos D; Sá-Nunes A; de Paula L; Matias-Peres C; Jamur MC; Oliver C; Serra MF; Martins MA; Faccioli LH
Eur J Immunol; 2006 Jun; 36(6):1494-503. PubMed ID: 16703563
[TBL] [Abstract][Full Text] [Related]
20. Comparison of substance P-induced and compound 48/80-induced neutrophil infiltrations in mouse skin.
Tomoe S; Iwamoto I; Tomioka H; Yoshida S
Int Arch Allergy Immunol; 1992; 97(3):237-42. PubMed ID: 1375205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
